IL23A and psoriasis: In a model of imiquimod-induced psoriasis in mice, it was described an increase of Foxp3+ Tregs in the skin and restoration of their suppressive function following use of IL-17 or IL-23 blocking antibodies but not with an anti-TNF-α treatment [55].